Founded in Brisbane, Australia with US and European operations, ImpediMed is a medical technology company that uses bioimpedance spectroscopy (BIS) technology to generate powerful data to maximize patient health. ImpediMed produces the SOZO Digital Health Platform, which is FDA-cleared, CE-marked, and ARTG-listed for multiple indications, including lymphoedema, heart failure, and protein calorie malnutrition and sold in select markets globally.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/07/25 | $15,000,000 | Growth |
SWK Holdings Corporation | undisclosed |
